Literature DB >> 28436948

Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.

J Li1, Q Huang1, X Long1, X Guo1, X Sun1, X Jin2, Z Li1, T Ren1, P Yuan3, X Huang1, H Zhang3, J Xing1.   

Abstract

To date, mechanisms of tumour cell survival under energy stress are not well understood. Cumulative evidence is beginning to reveal that specific mitochondrial morphologies are often associated with energetic states and survival of cells. However, the functional roles of mitochondria in the metabolic adaptation of tumour cells to energy stress remain to be elucidated. In this study, we first investigated the changes in mitochondrial morphology induced by nutrition deprivation in tumour cells, and the underlying molecular mechanism. We then systematically explored glucose metabolism reprogramming by energy stress-induced alteration of mitochondrial morphology and its effect on tumour cell survival. Our results showed that starvation treatment resulted in a dramatic mitochondrial elongation, which was mainly mediated by DRP1S637 phosphorylation through protein kinase A activation and subsequent suppression of mitochondrial translocation of DRP1. We further observed that tumour cells under an energy stress condition exhibited a clear shift from glycolysis towards oxidative phosphorylation, which was reversed by the recovery of mitochondrial fission induced by forced expression of mutant DRP1S637A. Mechanistically, energy stress-induced mitochondrial elongation facilitated cristae formation and assembly of respiratory complexes to enhance oxidative phosphorylation, which in turn exhibited a feedback inhibitory effect on glycolysis through NAD+-dependent SIRT1 activation. In addition, our data indicated that DRP1S637-mediated mitochondrial elongation under energy stress was essential for tumour cell survival both in vitro and in vivo and predicted poor prognosis of hepatocellular carcinoma patients. Overall, our study demonstrates that remodelling of mitochondrial morphology plays a critical role in tumour cell adaptation to energy stress by reprogramming glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28436948     DOI: 10.1038/onc.2017.98

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  38 in total

1.  Dimer ribbons of ATP synthase shape the inner mitochondrial membrane.

Authors:  Mike Strauss; Götz Hofhaus; Rasmus R Schröder; Werner Kühlbrandt
Journal:  EMBO J       Date:  2008-03-06       Impact factor: 11.598

2.  The many faces of sirtuins: Coupling of NAD metabolism, sirtuins and lifespan.

Authors:  Eric Verdin
Journal:  Nat Med       Date:  2014-01       Impact factor: 53.440

Review 3.  AMPK: a nutrient and energy sensor that maintains energy homeostasis.

Authors:  D Grahame Hardie; Fiona A Ross; Simon A Hawley
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

4.  GSKIP- and GSK3-mediated anchoring strengthens cAMP/PKA/Drp1 axis signaling in the regulation of mitochondrial elongation.

Authors:  Joon-Khim Loh; Ching-Chih Lin; Ming-Chang Yang; Chia-Hua Chou; Wan-Shia Chen; Ming-Chang Hong; Chung-Lung Cho; Ching-Mei Hsu; Jiin-Tsuey Cheng; An-Kuo Chou; Chung-Hsing Chang; Chao-Neng Tseng; Chi-Huei Wang; Ann-Shung Lieu; Shen-Long Howng; Yi-Ren Hong
Journal:  Biochim Biophys Acta       Date:  2015-04-25

5.  Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress.

Authors:  Yoshiyuki Ikeda; Akihiro Shirakabe; Yasuhiro Maejima; Peiyong Zhai; Sebastiano Sciarretta; Jessica Toli; Masatoshi Nomura; Katsuyoshi Mihara; Kensuke Egashira; Mitsuru Ohishi; Maha Abdellatif; Junichi Sadoshima
Journal:  Circ Res       Date:  2014-10-20       Impact factor: 17.367

6.  Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.

Authors:  Haejin Yoon; Seung-Hyun Shin; Dong Hoon Shin; Yang-Sook Chun; Jong-Wan Park
Journal:  Biochem Biophys Res Commun       Date:  2014-01-11       Impact factor: 3.575

7.  Mitochondrial complex I deficiency enhances skeletal myogenesis but impairs insulin signaling through SIRT1 inactivation.

Authors:  Jin Hong; Bong-Woo Kim; Hyo-Jung Choo; Jung-Jin Park; Jae-Sung Yi; Dong-Min Yu; Hyun Lee; Gye-Soon Yoon; Jae-Seon Lee; Young-Gyu Ko
Journal:  J Biol Chem       Date:  2014-06-03       Impact factor: 5.157

Review 8.  Sirtuins in mammals: insights into their biological function.

Authors:  Shaday Michan; David Sinclair
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

9.  Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations.

Authors:  Hsiuchen Chen; Marc Vermulst; Yun E Wang; Anne Chomyn; Tomas A Prolla; J Michael McCaffery; David C Chan
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

10.  Mammalian Sirt1: insights on its biological functions.

Authors:  Shahedur Rahman; Rezuanul Islam
Journal:  Cell Commun Signal       Date:  2011-05-08       Impact factor: 5.712

View more
  39 in total

1.  AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.

Authors:  Miao Qi; Dan Dai; Jin Liu; Zhongqi Li; Panpan Liang; Yue Wang; Lu Cheng; Yihong Zhan; Zhifeng An; Yaoyao Song; Yana Yang; Xiaohui Yan; Hui Xiao; Huanjie Shao
Journal:  Oncogene       Date:  2020-01-31       Impact factor: 9.867

Review 2.  Mitochondrial dynamics and metastasis.

Authors:  Dario C Altieri
Journal:  Cell Mol Life Sci       Date:  2018-11-10       Impact factor: 9.261

Review 3.  Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology.

Authors:  Yali Deng; Doan T M Ngo; Jessica K Holien; Jarmon G Lees; Shiang Y Lim
Journal:  Curr Oncol Rep       Date:  2022-10-01       Impact factor: 5.945

4.  MAGI2-AS3 restrains proliferation, glycolysis, and triggers apoptosis in acute lymphoblastic leukemia via regulating miR-452-5p/FOXN3 pathway.

Authors:  Xiao-Guang Chen; Bing-Hua Dou; Jin-Dou An; Song Feng; Na Liu; Guang-Yao Sheng
Journal:  Iran J Basic Med Sci       Date:  2022-01       Impact factor: 2.532

5.  Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.

Authors:  Chiaki T Ishida; Yiru Zhang; Elena Bianchetti; Chang Shu; Trang T T Nguyen; Giulio Kleiner; Maria J Sanchez-Quintero; Catarina M Quinzii; Mike-Andrew Westhoff; Georg Karpel-Massler; Varun V Prabhu; Joshua E Allen; Markus D Siegelin
Journal:  Clin Cancer Res       Date:  2018-07-23       Impact factor: 12.531

6.  Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility.

Authors:  Stacey Aggarwal; Laura Gabrovsek; Lorene K Langeberg; Martin Golkowski; Shao-En Ong; F Donelson Smith; John D Scott
Journal:  J Biol Chem       Date:  2018-12-31       Impact factor: 5.157

7.  Selective autophagy of AKAP11 activates cAMP/PKA to fuel mitochondrial metabolism and tumor cell growth.

Authors:  Zhiqiang Deng; Xianting Li; Marian Blanca Ramirez; Kerry Purtell; Insup Choi; Jia-Hong Lu; Qin Yu; Zhenyu Yue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

8.  S616-p-DRP1 associates with locally invasive behavior of follicular cell-derived thyroid carcinoma.

Authors:  Ana Rita Lima; Marcelo Correia; Liliana Santos; Catarina Tavares; Elisabete Rios; Sule Canberk; Paula Soares; Manuel Sobrinho-Simões; Miguel Melo; Valdemar Máximo
Journal:  Endocrine       Date:  2020-11-20       Impact factor: 3.633

9.  lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.

Authors:  Jing Luo; Huishan Wang; Li Wang; Gaoming Wang; Yu Yao; Kai Xie; Xiaokun Li; Lin Xu; Yi Shen; Binhui Ren
Journal:  Mol Ther Nucleic Acids       Date:  2021-05-01       Impact factor: 8.886

Review 10.  Mitochondrial Dynamics and Liver Cancer.

Authors:  María Isabel Hernández-Alvarez; Antonio Zorzano
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.